Skip to the page content
Your donations
Passes our checks

Gavi Alliance

EIN 98-0593375 · Washington, DC

Public records show a registered, tax-exempt organization in good standing.

LegitimacyPassesRegistration and standingFinancial healthFair69 out of 100GovernanceStrong90 out of 100Impact evidenceReports resultsHow well its results are evidenced

What it says it does

TO SAVE LIVES AND PROTECT PEOPLE'S HEALTH BY INCREASING EQUITABLE AND SUSTAINABLE USE OF VACCINES.

Income
$2.5 billion
Spending
$3.1 billion
Spent on programs
97%
Reserves
11 months of spending
Largest source of income
government grants, 64%
Employees
20
Volunteers
56
Highest pay
$869,845, coo & acting cfo - until 06/24

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Financial health

Fair: 69 out of 100. Higher than 59% of charities in its peer group (international, over $100m).

  • Reserves

    28 of 35

    Spendable reserves would cover 11.0 months of spending.

  • Debt

    16 of 20

    It owes 25% of what it owns.

  • Living within its means

    0 of 15

    Spending exceeded income by 22% of income.

  • Income trend

    10 of 15

    Income fell 3% on the year before.

  • Spending floor

    15 of 15

    97% of spending went to programs and raising each dollar of donations cost 2 cents.

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Governance

Strong: 90 out of 100. Higher than 8% of charities in its peer group (international, over $100m).

  • Independent board

    25 of 25

    42 of 42 voting board members are independent.

  • Conflict of interest policy

    15 of 15

    Has a written conflict of interest policy.

  • Whistleblower policy

    8 of 8

    Has a written whistleblower policy.

  • Record keeping policy

    7 of 7

    Has a written policy on keeping and destroying records.

  • Board minutes

    5 of 5

    Keeps minutes of board meetings.

  • Board sees the tax return

    0 of 10

    Did not give the board a copy of this return before filing it.

  • Pay set independently

    5 of 5

    Sets its chief executive's pay through independent review and comparison.

  • Independent check of accounts

    15 of 15

    Its accounts were audited by an independent accountant.

  • No reported misuse

    10 of 10

    Reports no diversion of assets, excess benefits or loans to insiders.

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Impact evidence

Reports results. Its tax return states measurable results. These are its own figures and nobody has checked them.

Results it reports

  • 58 supported vaccine introductions and preventive campaigns took place, plus 50 outbreak response vaccination campaigns.Work delivered
  • 32.6 million girls were fully immunized against HPV.Change achieved
  • 17 countries accessed cholera, meningococcal and yellow fever vaccines through emergency stockpiles a total of 44 times.Work delivered
  • 57 supported countries increased breadth of protection with portfolio vaccines to 63%, up 8 percentage points.Change achieved
  • More than 72 million children were reached with supported routine vaccines.Work delivered
  • Nearly 2,700 cold chain equipment units were installed in the year.Work delivered
  • Supported countries reached DTP3 coverage of 82%.Change achieved
  • 10 markets for vaccines and immunisation products exhibited acceptable levels of healthy market dynamics.Change achieved
  • 12 innovative products were in the pipeline of commercial-scale manufacturers.Change achieved
  • 500,000 mpox vaccine doses were provided within a month of the WHO emergency declaration.Work delivered
  • The number of manufacturers supplying prequalified supported vaccines remained at 20.Change achieved

Read from the return by an AI model and shown only where the wording was found in the return. These are the charity's own figures.

Programs described in its return (1)
  1. $3.0 billion spent. THE VACCINE GOAL: INTRODUCE AND SCALE UP VACCINESIN 2024, LOWER-INCOME COUNTRIES PROTECTED MORE PEOPLE, AGAINST MORE DISEASES, THAN ANY YEAR IN HISTORY.- 58 GAVI-SUPPORTED VACCINE INTRODUCTIONS AND PREVENTIVE CAMPAIGNS TOOK PLACE IN 2024 IN ADDITION TO 50 OUTBREAK RESPONSE VACCINATION CAMPAIGNS SUPPORTED BY GAVI.- 32.6 MILLION GIRLS FULLY IMMUNIZED AGAINST HPV WITH GAVI SUPPORT IN 2024 ALONE MORE THAN THE PREVIOUS TEN YEARS COMBINED.- 17 COUNTRIES ACCESSED CHOLERA, MENINGOCOCCAL AND YELLOW FEVER VACCINES THROUGH GAVI-SUPPORTED EMERGENCY STOCKPILES A TOTAL OF 44 TIMES IN 2024.- 57 GAVI-SUPPORTED COUNTRIES INCREASED BREADTH OF PROTECTION WITH VACCINES IN THE GAVI PORTFOLIO TO 63%, UP 8 PERCENTAGE POINTS FROM 2023.THE EQUITY GOAL: STRENGTHEN HEALTH SYSTEMS TO INCREASE EQUITY IN IMMUNIZATIONIN GAVI 5.0/5.1, HEALTH SYSTEM STRENGTHENING (HSS) SUPPORT PRIORITIZES EQUITY IN IMMUNISATION DELIVERY, TO REDUCE THE NUMBER OF ZERO-DOSE AND UNDER-IMMUNIZED CHILDREN.- >72 MILLION CHILDREN WERE REACHED WITH GAVI-SUPPORTED ROUTINE VACCINES IN 2024 MORE THAN IN ANY YEAR PREVIOUSLY.- 48 COUNTRIES HAVE INSTALLED MORE THAN 64,000 COLD CHAIN EQUIPMENT (CCE) UNITS PROCURED BY UNICEF SUPPLY DIVISION THROUGH GAVI'S COLD CHAIN EQUIPMENT OPTIMIZATION PLATFORM (CCEOP) NEARLY 2,700 IN 2024 ALONE.- AVERAGE COVERAGE OF DTP3 IN 26 LOW-INCOME COUNTRIES SUPPORTED BY GAVI IS NOT YET BACK TO PRE-PANDEMIC LEVELS (I.E. 75% IN 2019) WHILE LOWER-INCOME COUNTRIES EXCEEDED 2019 COVERAGE BY 1 PP, REACHING 87% IN 2024.- IN 2024, GAVI-SUPPORTED COUNTRIES INCREASED DTP3 COVERAGE AT 82% (COMPARED TO THE 85% GLOBAL AVERAGE).THE SUSTAINABILITY GOAL: IMPROVE SUSTAINABILITY OF IMMUNIZATION PROGRAMS2024 WAS ANOTHER RECORD-BREAKING YEAR FOR CO-FINANCING: EVEN COUNTRIES FACING SIGNIFICANT CHALLENGES INCREASED THEIR COMMITMENT TO IMMUNIZATION.- US $255 MILLION WAS CONTRIBUTED BY COUNTRIES TOWARDS THE CO-FINANCING OF GAVI-SUPPORTED VACCINES IN 2024 THE HIGHEST AMOUNT YET AND A TESTAMENT TO COUNTRY OWNERSHIP AND THE LONG-TERM FINANCIAL SUSTAINABILITY OF GAVI-SUPPORTED VACCINES.- 55 VACCINE PROGRAMS ORIGINALLY INTRODUCED WITH GAVI FUNDING ARE NOW SELF-FINANCED BY COUNTRIES AS OF 2023, UP FROM 40 IN 2018.- 100% OF COUNTRIES FULLY MET THEIR 2024 CO-FINANCING OBLIGATION EXCEPT SIX WAIVERS FOR HUMANITARIAN CRISIS.- IN THE FACE OF FISCAL CHALLENGES, CLIMATE CHANGE, CONFLICT AND INSTABILITY, MOST GAVI-SUPPORTED COUNTRIES MAINTAINED OR INCREASED DOMESTIC RESOURCES FOR CO-FINANCING OF GAVI-SUPPORTED VACCINES IN 2024, BRINGING TO US $1.9 BILLION THEIR TOTAL CONTRIBUTION SINCE THE INTRODUCTION OF THE CO-FINANCING POLICY IN 2008.THE HEALTHY MARKETS GOAL: ENSURE HEALTHY MARKETS FOR VACCINES AND RELATED PRODUCTSGAVI'S MARKET SHAPING EFFORTS MAKE LIFE-SAVING VACCINES AND OTHER IMMUNISATION PRODUCTS MORE ACCESSIBLE AND AFFORDABLE FOR LOWER-INCOME COUNTRIES.- 10 MARKETS FOR VACCINES AND IMMUNISATION PRODUCTS EXHIBITED ACCEPTABLE LEVELS OF HEALTHY MARKET DYNAMICS IN 2024, MEETING THE TARGET FOR THE YEAR.- 12 INNOVATIVE PRODUCTS WERE WITHIN THE PIPELINE OF COMMERCIAL-SCALE MANUFACTURERS IN 2024, CONTINUING TO EXCEED THE ALLIANCE TARGET OF 8 BY 2025 WELL AHEAD OF SCHEDULE.- 500,000 MPOX VACCINE DOSES WITHIN A MONTH OF THE WHO EMERGENCY DECLARATION.- THROUGH GAVI'S MARKET SHAPING EFFORTS, THE NUMBER OF MANUFACTURERS SUPPLYING PREQUALIFIED GAVI-SUPPORTED VACCINES REMAINED AT 20 IN 2024 (WITH MORE THAN HALF BASED IN LOW- AND MIDDLE-INCOME COUNTRIES) COMPARED WITH 5 IN 2001.FURTHER INFORMATION ON GAVI'S PROGRESS TOWARDS ACHIEVING ITS STRATEGIC GOALS CAN BE FOUND IN ITS 2024 ANNUAL PROGRESS REPORT, ONLINE AT: HTTPS://WWW.GAVI.ORG/PROGRAMMES-IMPACT/OUR-IMPACT/PROGRESS-REPORTS.

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Legitimacy checks

  1. Is it registered with the IRS? Passed.

    Listed in the IRS master file of tax-exempt organizations as a 501(c)(3) charitable organization.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.

  2. Has the IRS revoked its tax-exempt status? Passed.

    Not on the IRS automatic revocation list.

    Source: Automatic revocation of exemption list, Internal Revenue Service, file dated October 13, 2026.

  3. Are donations tax-deductible? Passed.

    On the IRS list of organizations eligible to receive tax-deductible contributions.

    Source: Publication 78 data: organizations eligible for tax-deductible contributions, Internal Revenue Service, file dated October 13, 2026.

  4. Is it keeping up with its IRS filings? Passed.

    Most recent return on file covers the year ending December 2024.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.

  5. How long has it been tax-exempt? Passed.

    Recognized by the IRS since March 2009.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.

  6. Is it in good standing with state regulators? Passed.

    Not on California's list of charities barred from soliciting. Other states are not yet checked.

    Source: May Not Operate or Solicit for Charitable Purposes list, California Attorney General, Registry of Charities and Fundraisers, file dated October 21, 2026.

Ratings and checks are our reading of public records, using the published method. They are not a statement about anyone's honesty. If you work for this organization, you can send corrections or results, confirm you want gifts through Veridonate, or ask to be removed from giving.